申请人:THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
公开号:US11041207B2
公开(公告)日:2021-06-22
The present invention provides, inter alia, methods for treating or ameliorating the effects of a disorder, such as schizophrenia or bipolar disorder, by increasing or decreasing proline levels. Further provided are methods of predicting and monitoring the clinical response in a patient, and diagnostic systems for identifying a patient likely to benefit from proline modulation.
本发明特别提供了通过增加或减少脯氨酸水平来治疗或改善精神分裂症或双相情感障碍等疾病的方法。本发明还提供了预测和监测患者临床反应的方法,以及用于识别可能从脯氨酸调节中获益的患者的诊断系统。